Oral and Intravenous Amoxicillin Dosing Recommendations in Neonates: A Pooled Population Pharmacokinetic Study
Clinical Infectious Diseases · 30.11.2023 · 77 (11) · 1595-1603
DOI: 10.1093/cid/ciad432 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Infectious Diseases, online erschienen am 27.09.2023. Verfasst von Fleur M Keij und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatrics, Division of Neonatology, Erasmus University Medical Centre-Sophia Children's Hospital, Rotterdam, The Netherlands. Hauptthemen laut MEDLINE: Amoxicillin, Bacterial Infections. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: ZonMw, the Netherlands Organization for Health Research and Development, Innovatiefonds Zorgverzekeraars.
Abstract (Originalsprache)
Background
There is a lack of evidence on oral amoxicillin pharmacokinetics and exposure in neonates with possible serious bacterial infection (pSBI). We aimed to describe amoxicillin disposition following oral and intravenous administration and to provide dosing recommendations for preterm and term neonates treated for pSBI.
Methods
In this pooled-population pharmacokinetic study, 3 datasets were combined for nonlinear mixed-effects modeling. In order to evaluate amoxicillin exposure following oral and intravenous administration, pharmacokinetic profiles for different dosing regimens were simulated with the developed population pharmacokinetic model. A target of 50% time of the free fraction above the minimal inhibitory concentration (MIC) with an MICECOFF of 8 mg/L (to cover gram-negative bacteria such as Escherichia coli) was used.
Results
The cohort consisted of 261 (79 oral, 182 intravenous) neonates with a median (range) gestational age of 35.8 weeks (range, 24.9–42.4) and bodyweight of 2.6 kg (range, 0.5–5). A 1-compartment model with first-order absorption best described amoxicillin pharmacokinetics. Clearance (L/h/kg) in neonates born after 30 weeks’ gestation increased with increasing postnatal age (PNA day 10, 1.25-fold; PNA day 20, 1.43-fold vs PNA day 3). Oral bioavailability was 87%. We found that a twice-daily regimen of 50 mg/kg/day is superior to a 3- or 4-times daily schedule in the first week of life for both oral and intravenous administration.
Conclusions
This pooled population pharmacokinetic description of intravenous and oral amoxicillin in neonates provides age-specific dosing recommendations. We conclude that neonates treated with oral amoxicillin in the first weeks of life reach adequate amoxicillin levels following a twice-daily dosing regimen. Oral amoxicillin therapy could therefore be an adequate, cost-effective, and more patient-friendly alternative for neonates worldwide.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Paediatrics, Division of Neonatology, Erasmus University Medical Centre-Sophia Children's Hospital, Rotterdam, The Netherlands.
- Department of Paediatrics, Franciscus Gasthuis & Vlietland, Rotterdam, The Netherlands.
- Department of Hospital Pharmacy, Erasmus University Medical Centre, Rotterdam, The Netherlands.
- Rotterdam Clinical Pharmacometrics Group, Erasmus University Medical Centre, Rotterdam, The Netherlands.
- Section of Paediatric Infectious Disease, Paediatrics and Child Health, Aga Khan University, Karachi, Pakistan.
- Department of Paediatrics, Division of Neonatology, Maastricht University Medical Centre, Maastricht, The Netherlands.
ORCID-Profile: Fleur M Keij
Förderung
- ZonMw
- the Netherlands Organization for Health Research and Development
- Innovatiefonds Zorgverzekeraars
- Sophia Foundation
Zitieren
APA
Keij, F. M., Schouwenburg, S., Kornelisse, R. F., Preijers, T., Mir, F., Degraeuwe, P., Stolk, L. M., van Driel, A., Kenter, S., van der Sluijs, J., Heidema, J., den Butter, P. C. P., Reiss, I. K. M., Allegaert, K., Tramper-Stranders, G. A., Koch, B. C. P., & Flint, R. B. (2023). Oral and Intravenous Amoxicillin Dosing Recommendations in Neonates: A Pooled Population Pharmacokinetic Study. Clinical Infectious Diseases, 77(11), 1595-1603. https://doi.org/10.1093/cid/ciad432
Vancouver
Keij FM, Schouwenburg S, Kornelisse RF, Preijers T, Mir F, Degraeuwe P, et al. Oral and Intravenous Amoxicillin Dosing Recommendations in Neonates: A Pooled Population Pharmacokinetic Study. Clinical Infectious Diseases. 2023;77(11):1595-1603. doi:10.1093/cid/ciad432
BibTeX
@article{Keij2023,
author = {Keij, Fleur M and Schouwenburg, Stef and Kornelisse, René F and Preijers, Tim and Mir, Fatima and Degraeuwe, Pieter and Stolk, Leo M and van Driel, Arianne and Kenter, Sandra and van der Sluijs, Jacqueline and Heidema, Jojanneke and den Butter, Paul C P and Reiss, Irwin K M and Allegaert, Karel and Tramper-Stranders, Gerdien A and Koch, Birgit C P and Flint, Robert B},
title = {Oral and Intravenous Amoxicillin Dosing Recommendations in Neonates: A Pooled Population Pharmacokinetic Study},
journal = {Clinical Infectious Diseases},
year = {2023},
volume = {77},
number = {11},
pages = {1595--1603},
doi = {10.1093/cid/ciad432}
}
EUVIMED